Stock listing

Frankfurt:CUS Curasight A/S Aktie

German listing (Frankfurt) of Curasight A/S · home listing NGM:CURAS

Follow Curasight A/S into a list and get an email when it puts out news.

Curasight A/S logo
Ticker
Frankfurt:CUS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

Curasight Announces protocol update for the Phase I uTREAT trial in Aggressive Brain Cancer (Glioblastoma)

Jul 27, 2026

Curasight A/S has successfully completed a directed issue of shares of approximately DKK 20 million

Jun 22, 2026

Curasight A/S announces its intention to carry out a directed issue of shares

Jun 22, 2026

Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT[®] in Aggressive Brain Cancer (Glioblastoma)

Jun 8, 2026

Curasight: Major Shareholding Notification - share transfer and ownership restructuring – related party transaction

Apr 26, 2026

Major Shareholding Notification - share transfer and ownership restructuring - related party transaction

Apr 26, 2026

Resolutions of the Annual General Meeting 2026 of Curasight A/S

Mar 25, 2026

Curasight: Notice of Annual General Meeting 2026

Mar 10, 2026

Curasight reduces debt through Fenja Capital conversion

Mar 9, 2026

Curasight reduces convertible debt as Fenja Capital converts and enters into a block trade

Mar 6, 2026

All Curasight A/S news

Decks

Curasight A/S on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 17 in all · newest Jul 27, 2026 · oldest 2025
Decks
2 decks · latest May 2025

Where Curasight A/S is listed

ListingExchangeCountryCurrency
NGM:CURAS · Home listingNGMSwedenDKK
Frankfurt:CUS · This pageFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Curasight A/S.